- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07744958
RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)
July 30, 2026 updated by: Dr. Camilla Grunewald, Heinrich-Heine University, Duesseldorf
Removal of the urinary bladder (radical cystectomy) is a major surgical procedure that can have a permanent impact on a patient's quality of life.
Consequently, some patients, despite having received comprehensive counseling and completing systemic therapy, decide against subsequent surgery or alternative radiotherapy.
Recent scientific studies suggest that, for selected patients, an attempt at bladder preservation may be a medically justifiable option.
However, it remains unclear which patients are truly suitable candidates for bladder-preserving management and which are not.
The aim of this registry is therefore to collect and analyze clinical data from this specific patient population.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Camilla Grunewald, Dr. med.
- Phone Number: 00492118119353
- Email: camillamarisa.grunewald@med.uni-duesseldorf.de
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patient with muscle-invasive urothelial carcinoma of the bladder who decline to undergo radical cystectomy or radiotherapy after systemic therapy (perioperative attempt)
Description
Inclusion Criteria:
- Patients aged >= 18 years, capable of providing informed consent
- Histologically confirmed muscle-invasive urothelial carcinoma of the urinary bladder
- Received perioperative systemic therapy in accordance with current guidelines and subsequently decline cystectomy or radiotherapy
Exclusion Criteria:
- Age < 18 years
- Lack of capacity to provide informed consent
- No histological confirmed muscle-invasive urothelial carcinoma
- No prior preoperative systemic therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
2 year MFS
Time Frame: 2 Years
|
Metastatic free survival after two years
|
2 Years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
December 1, 2029
Study Registration Dates
First Submitted
July 30, 2026
First Submitted That Met QC Criteria
July 30, 2026
First Posted (Actual)
August 4, 2026
Study Record Updates
Last Update Posted (Actual)
August 4, 2026
Last Update Submitted That Met QC Criteria
July 30, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24072026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.